Product Information
TRIFLUOPERAZINE 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $1.2729 per EA under NDC 00781803601. Its NADAC has been published 138 times since Mar 13, 2019.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781803601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIFLUOPERAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085788On Market Since
11/20/1981
Pharmacological Classes
Price Statistics
The NADAC for TRIFLUOPERAZINE 10 MG TABLET has been published 138 times since Mar 13, 2019, and over the history we have for it it has declined 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2729 per EA |
|---|---|
| All-time high | $1.5413 (May 14, 2025) |
| All-time low | $1.0012 (Jul 17, 2024) |
| 52-week high | $1.4950 |
| 52-week low | $1.2729 |
| Median price | $1.3403 |
| Average price | $1.3531 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Trifluoperazine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TRIFLUOPERAZINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIFLUOPERAZINE 10 MG TABLET, manufactured by Sandoz Inc., is $1.2729 per EA (NDC 00781803601), effective Jun 24, 2026.
How has the price of TRIFLUOPERAZINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIFLUOPERAZINE 10 MG TABLET has declined 5.0%. It has been tracked across 138 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for TRIFLUOPERAZINE 10 MG TABLET?
Since Mar 13, 2019, the NADAC for TRIFLUOPERAZINE 10 MG TABLET has ranged from a low of $1.0012 (Jul 17, 2024) to a high of $1.5413 (May 14, 2025), with a median of $1.3403 per EA.
Are there cheaper alternatives to TRIFLUOPERAZINE 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TRIFLUOPERAZINE 10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TRIFLUOPERAZINE 10 MG TABLET?
TRIFLUOPERAZINE 10 MG TABLET (NDC 00781803601) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification